Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $323M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | LABORATORY CORP AMER HLDGS | 168,809 | $33.94M | 10.5% | $201.05 | $234.91 | — | COM NEW | 50540R409 |
| GMED | GLOBUS MED INC | 516,981 | $25.67M | 7.9% | $49.65 * | $57.29 | -2.4% | CL A | 379577208 |
| GSK | GSK PLC | 509,000 | $18.45M | 5.7% | $36.25 | $35.68 | — | SPONSORED ADR | 37733W204 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 81,606 | $18.43M | 5.7% | $225.87 | $190.39 | +21.0% | COM | 91307C102 |
| CI | THE CIGNA GROUP | 58,226 | $16.66M | 5.2% | $286.07 * | $228.19 | +19.5% | COM | 125523100 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 242,308 | $16.49M | 5.1% | $68.04 * | $76.71 | -5.5% | COMMON STOCK | 36266G107 |
| BCYC | BICYCLE THERAPEUTICS PLC | 796,933 | $16.01M | 5.0% | $20.09 | $20.48 | — | SPONSORED ADS | 088786108 |
| PFE | PFIZER INC | 450,700 | $14.95M | 4.6% | $33.17 * | $30.57 | 0.0% | COM | 717081103 |
| OGN | ORGANON & CO | 767,000 | $13.32M | 4.1% | $17.36 * | $24.16 | -23.2% | COMMON STOCK | 68622V106 |
| TFX | TELEFLEX INCORPORATED | 64,491 | $12.67M | 3.9% | $196.41 * | $222.37 | 0.0% | COM | 879369106 |
| REGN | REGENERON PHARMACEUTICALS | 15,250 | $12.55M | 3.9% | $822.96 * | $781.58 | 0.0% | COM | 75886F107 |
| MDT | MEDTRONIC PLC | 110,780 | $8.681M | 2.7% | $78.36 | $77.80 | 0.0% | SHS | G5960L103 |
| EMBC | EMBECTA CORP | 568,294 | $8.553M | 2.6% | $15.05 * | $16.94 | 0.0% | COMMON STOCK | 29082K105 |
| HCSG | HEALTHCARE SVCS GROUP INC | 810,307 | $8.452M | 2.6% | $10.43 * | $12.44 | 0.0% | COM | 421906108 |
| OFIX | ORTHOFIX MED INC | 650,000 | $8.359M | 2.6% | $12.86 * | $17.99 | 0.0% | COM | 68752M108 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 73,400 | $8.237M | 2.5% | $112.22 * | $124.17 | 0.0% | COM | 98956P102 |
| TVTX | TRAVERE THERAPEUTICS INC | 884,770 | $7.91M | 2.4% | $8.94 * | $14.11 | 0.0% | COM | 89422G107 |
| VKTX | VIKING THERAPEUTICS INC | 595,002 | $6.587M | 2.0% | $11.07 * | $15.74 | -9.1% | COM | 92686J106 |
| — | GRACELL BIOTECHNOLOGIES INC | 2,081,216 | $5.994M | 1.9% | $2.88 | $2.88 | — | SPONSORED ADS | 38406L103 |
| BBIO | BRIDGEBIO PHARMA INC | 222,947 | $5.879M | 1.8% | $26.37 * | $28.38 | 0.0% | COM | 10806X102 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 756,891 | $4.897M | 1.5% | $6.47 | $5.26 | — | SPONSORED ADS | 152309100 |
| SPRY | ARS PHARMACEUTICALS INC | 1,105,911 | $4.18M | 1.3% | $3.78 * | $6.60 | -0.6% | COM | 82835W108 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 248,127 | $4.139M | 1.3% | $16.68 * | $19.40 | 0.0% | COM | 74366E102 |
| — | KARUNA THERAPEUTICS INC | 24,129 | $4.08M | 1.3% | $169.09 | $169.09 | — | COM | 48576A100 |
| — | REVANCE THERAPEUTICS INC | 342,477 | $3.928M | 1.2% | $11.47 | $17.19 | — | COM | 761330109 |
| — | IMMUNOGEN INC | 232,751 | $3.694M | 1.1% | $15.87 | $18.87 | — | COM | 45253H101 |
| — | MERRIMACK PHARMACEUTICALS IN | 288,466 | $3.557M | 1.1% | $12.33 | $11.58 | — | COM NEW | 590328209 |
| SVRA | SAVARA INC | 896,250 | $3.388M | 1.0% | $3.78 * | $1.37 | +160.7% | COM | 805111101 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 635,969 | $3.377M | 1.0% | $5.31 * | $9.70 | -12.3% | COM | 03969K108 |
| ADCT | ADC THERAPEUTICS SA | 3,294,534 | $2.955M | 0.9% | $0.90 * | $3.02 | -56.0% | SHS | H0036K147 |
| — | X4 PHARMACEUTICALS INC | 2,599,003 | $2.833M | 0.9% | $1.09 | $1.66 | — | COM | 98420X103 |
| RVMD | REVOLUTION MEDICINES INC | 72,700 | $2.012M | 0.6% | $27.68 * | $29.66 | 0.0% | COM | 76155X100 |
| IDYA | IDEAYA BIOSCIENCES INC | 74,007 | $1.997M | 0.6% | $26.98 * | $13.45 | +88.5% | COM | 45166A102 |
| NYXH | NYXOAH SA | 200,076 | $1.411M | 0.4% | $7.05 * | $7.82 | +0.1% | SHS | B6S7WD106 |
| APRE | APREA THERAPEUTICS INC | 280,000 | $1.167M | 0.4% | $4.17 * | $7.27 | -49.9% | COM NEW | 03836J201 |
| PRLD | PRELUDE THERAPEUTICS INC | 350,000 | $1.081M | 0.3% | $3.09 * | $3.75 | 0.0% | COM | 74065P101 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS INC | 150,000 | $1.011M | 0.3% | $6.74 * | $4.38 | +58.2% | COM NEW | 21833P301 |
| — | REPARE THERAPEUTICS INC | 76,049 | $919K | 0.3% | $12.08 | $9.84 | — | COM | 760273102 |
| SGHT | SIGHT SCIENCES INC | 246,699 | $831K | 0.3% | $3.37 * | $6.57 | 0.0% | COM | 82657M105 |
| MODD | MODULAR MED INC | 689,352 | $800K | 0.2% | $1.16 * | $4.31 | -75.3% | COM NEW | 60785L207 |
| — | HARPOON THERAPEUTICS INC | 168,017 | $677K | 0.2% | $4.03 | $4.03 | — | COM NEW | 41358P205 |
| — | FUSION PHARMACEUTICALS INC | 246,036 | $640K | 0.2% | $2.60 | $11.22 | — | COM | 36118A100 |
| — | ASLAN PHARMACEUTICALS LTD | 254,150 | $478K | 0.1% | $1.88 | $2.88 | — | SPON ADS NEW | 04522R200 |
| VNDA | VANDA PHARMACEUTICALS INC | 97,616 | $422K | 0.1% | $4.32 * | $11.29 | -50.8% | COM | 921659108 |
| INGN | INOGEN INC | 52,794 | $276K | 0.1% | $5.22 * | $31.10 | -77.1% | COM | 45780L104 |
| — | NEXTCURE INC | 130,000 | $168K | 0.1% | $1.29 | $6.00 | — | COM | 65343E108 |
| — | MOLECULIN BIOTECH INC | 271,230 | $116K | 0.0% | $0.43 | $4.03 | — | COM | 60855D200 |
| — | VINCERX PHARMA INC | 102,049 | $103K | 0.0% | $1.01 | $18.89 | — | COM NEW | 92731L106 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 400,000 | $69,800 | 0.0% | $0.17 | $0.16 | — | *W EXP 09/02/202 | 77313F114 |
| — | CAREMAX INC | 30,741 | $65,171 | 0.0% | $2.12 | $8.24 | — | COM CL A | 14171W103 |
| HUMAW | HUMACYTE INC | 49,998 | $33,439 | 0.0% | $0.67 | $0.60 | — | *W EXP 08/27/202 | 44486Q111 |
| — | CAREMAX INC | 12,808 | $2,369 | 0.0% | $0.18 | $0.44 | — | *W EXP 06/08/202 | 14171W111 |